Correlation Between Biofrontera Warrants and Bone Biologics

Can any of the company-specific risk be diversified away by investing in both Biofrontera Warrants and Bone Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofrontera Warrants and Bone Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biofrontera Warrants and Bone Biologics Corp, you can compare the effects of market volatilities on Biofrontera Warrants and Bone Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofrontera Warrants with a short position of Bone Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofrontera Warrants and Bone Biologics.

Diversification Opportunities for Biofrontera Warrants and Bone Biologics

-0.69

Correlation Coefficient

Biofrontera Warrants  Bone Biologics

Excellent diversification

The 3 months correlation between Biofrontera and Bone is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Biofrontera Warrants and Bone Biologics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bone Biologics Corp and Biofrontera Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofrontera Warrants are associated (or correlated) with Bone Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bone Biologics Corp has no effect on the direction of Biofrontera Warrants i.e., Biofrontera Warrants and Bone Biologics go up and down completely randomly.

Pair Corralation between Biofrontera Warrants and Bone Biologics

Assuming the 90 days horizon Biofrontera Warrants is expected to generate 11.13 times more return on investment than Bone Biologics. However, Biofrontera Warrants is 11.13 times more volatile than Bone Biologics Corp. It trades about 0.14 of its potential returns per unit of risk. Bone Biologics Corp is currently generating about -0.03 per unit of risk. If you would invest  20.00  in Biofrontera Warrants on September 25, 2024 and sell it today you would lose (9.00) from holding Biofrontera Warrants or give up 45.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	64.79%
Values	Daily Returns

Biofrontera Warrants  vs.  Bone Biologics Corp

Biofrontera Warrants

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Biofrontera Warrants are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Biofrontera Warrants showed solid returns over the last few months and may actually be approaching a breakup point.

Bone Biologics Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bone Biologics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's essential indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Biofrontera Warrants and Bone Biologics

The main advantage of trading using opposite Biofrontera Warrants and Bone Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofrontera Warrants position performs unexpectedly, Bone Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bone Biologics will offset losses from the drop in Bone Biologics' long position.

The idea behind Biofrontera Warrants and Bone Biologics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.